Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MUHAMMAD OWAIS MALIK

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1376910208
CMS profile
7874009
Location
JOHNSON CITY, TN

General Payments · PY2020–2024

$1,986.34

  • Reported across 91 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$800.99

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $776.38 35
Education $24.61 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $194.01 11
PY2021 $115.36 7
PY2022 $429.84 15
PY2023 $446.14 22
PY2024 $800.99 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $24.61 08/27/2024 Education Undisputed 01/23/2026 1145832933 CMS
Amgen Inc. $25.05 03/05/2024 Food and Beverage Undisputed 01/23/2026 1117618210 CMS
Amgen Inc. $21.77 05/08/2024 Food and Beverage Undisputed 01/23/2026 1117618212 CMS
Amgen Inc. $21.48 05/09/2024 Food and Beverage Undisputed 01/23/2026 1115895632 CMS
Amgen Inc. $125.00 05/30/2024 Food and Beverage Undisputed 01/23/2026 1117618216 CMS
Amgen Inc. $25.60 06/19/2024 Food and Beverage Undisputed 01/23/2026 1117618214 CMS
Amgen Inc. $4.14 11/21/2024 Food and Beverage Undisputed 01/23/2026 1117618218 CMS
Amgen Inc. $16.37 12/11/2024 Food and Beverage Undisputed 01/23/2026 1117618220 CMS
AstraZeneca Pharmaceuticals LP $17.98 01/24/2024 Food and Beverage Undisputed 01/23/2026 1105611119 CMS
AstraZeneca Pharmaceuticals LP $20.36 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105806172 CMS
AstraZeneca Pharmaceuticals LP $17.91 02/21/2024 Food and Beverage Undisputed 01/23/2026 1105504106 CMS
AstraZeneca Pharmaceuticals LP $19.31 03/06/2024 Food and Beverage Undisputed 01/23/2026 1104371625 CMS
AstraZeneca Pharmaceuticals LP $21.44 05/02/2024 Food and Beverage Undisputed 01/23/2026 1105206534 CMS
AstraZeneca Pharmaceuticals LP $19.59 06/20/2024 Food and Beverage Undisputed 01/23/2026 1105827615 CMS
AstraZeneca Pharmaceuticals LP $23.06 07/10/2024 Food and Beverage Undisputed 01/23/2026 1105672877 CMS
AstraZeneca Pharmaceuticals LP $22.77 07/24/2024 Food and Beverage Undisputed 01/23/2026 1105760853 CMS
AstraZeneca Pharmaceuticals LP $17.30 08/14/2024 Food and Beverage Undisputed 01/23/2026 1105675895 CMS
AstraZeneca Pharmaceuticals LP $24.58 11/20/2024 Food and Beverage Undisputed 01/23/2026 1105441959 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.71 11/25/2024 Food and Beverage Undisputed 01/23/2026 1086139663 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.59 10/24/2024 Food and Beverage Undisputed 01/23/2026 1117986979 CMS
CALLIDITAS THERAPEUTICS US INC. $26.58 10/22/2024 Food and Beverage Undisputed 01/23/2026 1141525220 CMS
CALLIDITAS THERAPEUTICS US INC. $24.16 12/18/2024 Food and Beverage Undisputed 01/23/2026 1141529855 CMS
Fresenius USA Marketing, Inc. $20.30 05/13/2024 Food and Beverage Undisputed 01/23/2026 1154206038 CMS
Fresenius USA Marketing, Inc. $16.75 07/05/2024 Food and Beverage Undisputed 01/23/2026 1154206034 CMS
Fresenius USA Marketing, Inc. $18.84 10/17/2024 Food and Beverage Undisputed 01/23/2026 1154206036 CMS
Lilly USA, LLC $26.07 08/29/2024 Food and Beverage Undisputed 01/23/2026 1135175025 CMS
Mallinckrodt Hospital Products Inc. $22.87 11/11/2024 Food and Beverage Undisputed 01/23/2026 1145102910 CMS
Novartis Pharmaceuticals Corporation $22.77 09/13/2024 Food and Beverage Undisputed 01/23/2026 1087112404 CMS
Novartis Pharmaceuticals Corporation $19.95 09/19/2024 Food and Beverage Undisputed 01/23/2026 1087112406 CMS
Novartis Pharmaceuticals Corporation $16.65 10/03/2024 Food and Beverage Undisputed 01/23/2026 1087112408 CMS
Novo Nordisk Inc $17.93 08/05/2024 Food and Beverage Undisputed 01/23/2026 1097076479 CMS
OPKO Pharmaceuticals, LLC $16.56 09/03/2024 Food and Beverage Undisputed 01/23/2026 1112846902 CMS
Otsuka America Pharmaceutical, Inc. $19.57 05/29/2024 Food and Beverage Undisputed 01/23/2026 1118934780 CMS
Travere Therapeutics, Inc. $1.96 07/11/2024 Food and Beverage Undisputed 01/23/2026 1149947411 CMS
Travere Therapeutics, Inc. $13.15 07/11/2024 Food and Beverage Undisputed 01/23/2026 1149947415 CMS
Travere Therapeutics, Inc. $16.26 12/04/2024 Food and Beverage Undisputed 01/23/2026 1149947419 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.